201 results about "Class Mammalia" patented technology

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.

The current invention provides a biocompatible energy recharge system to normalize body functions for a mammal. Both stationary and circulatory scalar wave energy was produced and utilized to enable the entire body of a mammal to increase the energy potential of any cell in the body, to promote cell growth, to facilitate cell repair, and to reduce cell destruction, hence the cells, organs, systems and the entire body of a mammal become healthy, and to treat a disease or disorder. The invention is a combination of the generators of the three-dimensional bio-waves in the stationary and in the circulationary formats for empowering the cells in all parts of a mammal, and a method of using the 3D bio-waves uniformly to empower each organ of a mammal to restore and maintain the normal body health and function.

Exemplary embodiments include a computer-implemented method of training a neural network and / or a large language model for automatically collecting, analyzing, and transmitting data to induce a mental state and change a behavior in a mammal.

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.

The invention relates to a measuring device for the non-invasive determination of a blood sugar concentration in the body of a mammal, comprising a housing (G), a measuring electronics (IC) in the housing (G), wherein the measuring electronics (IC) further comprises at least one transmitter (Tx) for emitting high-frequency signals with a frequency of more than 0.1 THz and less than 10 THz, at least one receiver (Rx) for receiving high-frequency signals with a frequency of more than 0.1 THz and less than 10 THz, wherein the at least one transmitter (Tx) is designed such that during operation it emits the high-frequency signal via an antenna (ANT_Tx) integrated in the measuring device, wherein the at least one receiver (Rx) is designed such that, during operation, it receives a high-frequency signal via an antenna (ANT_Rx) integrated in the measuring device, wherein the measuring device is configured to be attached relative to a nail plate (NP) on a nail of a finger or toe of the mammal, wherein the high-frequency signals from at least one transmitter (Tx) are coupled through the nail plate (NP) into the nail bed (NB) of the mammal during operation, and wherein the high-frequency signals backscattered from the nail bed (NB) of the mammal through the nail plate (NP) during operation are received by at least one receiver (Rx), wherein the measuring device further comprises an evaluation device (CPU) which is configured to evaluate the backscattered high-frequency signals received by at least one receiver (Rx) in order to determine the blood sugar concentration in the body of a mammal.

A composition comprising BpPA26 is provided. The composition is for use in vaccine therapy to treat or prevent pathogenic Burkholderia species infection in a mammal, typically a human or an equine mammal. The species include Burkholderia cepacia complex, Burkholderia mallei, and Burkholderia pseudomallei.

This document relates to methods and materials for using 4-aminopyridine (4-AP) and / or one or more derivatives of 4-AP. For example, a composition containing 4-AP and / or one or more derivatives of 4-AP can be administered (e.g., orally administered) to a mammal to increase a level of bone morphogenetic protein 2 (BMP-2) polypeptides within the mammal. For example, a composition containing 4-AP and / or one or more derivatives of 4-AP can be administered (e.g., orally administered) to a mammal having bone loss to increase the level of BMP-2 within the mammal, thereby treating the mammal's bone loss.

The present invention relates to a steerable device (10) comprising an elongate element (12) configured to traverse through a mammalian body in a navigational manner. The elongate element (12) has a device tip (20) configured to allow manipulation of the elongate element (12) by an external magnetic field. Further, the device tip (20) comprises a plurality of segments (26), each segment (26) comprising a segment body (36) and a segment interface (38a, 38b), and a plurality of connectors (24), each connector (24) comprising a connector body (40) and a connector interface (42a, 42b). The connector interfaces (42a, 42b) and the segment interfaces (38a, 38b) each have complementary shapes to allow rotational movement relative to each other and to form a connection to maintain the connector and the segment in a mated state, and the magnetic element (34) at least partially forms the segment body or the connector body or both.

The invention relates to the veterinary field and, more particularly, non-rinsed compositions comprising an active ingredient obtained from Ophiopogon Japonicus, panthenol and saccharide isomerate, for non-human mammals. The invention also relates to a method for treating the fur of non-human mammals by applying said non-rinsed compositions to the fur and / or the skin.

The invention relates to a transfer assembly (1) intended to be integrated into a device suitable for transferring, into a female mammal, material or substance for reproductive, therapeutic or diagnostic purposes contained in the internal space of a straw, characterized in that the assembly (1) comprises: a protective sheath (5) having open proximal and distal ends (5b) and an internal axial conduit (50) extending between the proximal and distal ends (5b);and a connecting element (4) integral with the sheath (5) and introduced axially into the conduit (50), the connecting element (4) being a hollow body having open proximal (4a) and distal (4b) ends and a longitudinal passage (6) extending between the proximal (4a) and distal (4b) ends, the connecting element (4) comprising a proximal portion (40) intended to cooperate with the straw and a distal portion (41) intended to cooperate with the proximal end of an inner sheath of the device, the proximal portion (40) comprising means for retaining the straw. Figure to be published with the abbreviation: Figure 5.;

Methods for improving quality of life and / or increasing activity in an aging and / or chronically ill mammal via administration of a composition of egg powder protein are provided.

This document relates to methods and materials involved in assessing and / or treating mammals having a caveolinopathy disease (e.g., immune-mediated rippling muscle disease (iRMD)). For example, methods and materials for detecting the presence of an autoantibody specific for a caveolae-associated protein 4 (cavin-4) polypeptide to identify a mammal as having iRMD as well as methods for treating a mammal identified having iRMD are provided. In some cases, cavin-4 polypeptides (and / or fragments thereof and / or variants thereof) can be used to detect the presence or absence of anti-cavin-4 polypeptide autoantibodies indicative of iRMD.

The invention discloses application of spermidine in preparation of a preparation for improving fertility of female mammals, and belongs to the technical field of reproductive biology. According to the invention, spermidine with different concentrations is introduced into mice, and the effect of spermidine on ovarian hormone secretion, ovarian reserve level and follicle number of female mammals is determined in a diet intake manner, so that the fertility of female animals is improved; it is found that spermidine can effectively improve the ovarian function, increase the secretion level of E2, P4, LH and AMH hormones closely related to the ovarian function, reduce the number of atresia follicles of the ovarian and increase the litter birth number of female mice by 1-2, and the spermidine has good animal breeding and livestock raising application prospects.

The present invention relates to the field of mammalian reproduction and use of a GnRH antagonist in the regulation and control of estrus of a mammal. The GnRH antagonist can inhibit oestrus for a longer time with less frequent use, and can be used for estrus synchronization and batch reproduction of livestock husbandry animals or regulation and control of estrus of pets.

A method for promoting weight management in a mammal is provided, comprising administering to the mammal a weight loss agent and a mitochondria enhancing agent. Compositions for weight management are also provided.

Devices and methods for treatment of a tunnel wound in a mammal are disclosed. A device can include a suture, a tunnel filler, and a cap member. The suture can be folded to form a proximal loop and two distal ends. The tunnel filler can be compressed onto the suture between the proximal loop and the two distal ends. And the cap member can be positioned on the suture distal to the tunnel filler. The tunnel filler can comprise decellularized mammalian extracellular matrix. The device can further include a tamp member positioned over the suture distal to the cap member. A method of treating a tunnel wound can include introducing the device into the tunnel wound, applying pressure to an end of the tunnel filler by sliding the tamp member along the suture, removing the tamp member from the suture, and securing an end of the suture to an end of the tunnel wound.

The utility model discloses a cage for assisting large animals to stand after surgery, comprising a cage base, the four end corners of the lower end surface of the cage base are rotatably connected with universal pulleys, a drain plate is installed on the inner side of the cage base, a movable tray is slidably connected between the cage base and the drain plate, a handle is provided on the front end surface of the movable tray, a metal cage frame is fixedly installed on the upper end surface of the cage base, and blocking side doors are installed on both sides of the metal cage frame; a fixed frame is fixedly installed on the upper end surface of the metal cage frame, an upper sealing plate is fixedly installed on the inner side of the fixed frame, and an elastic abdominal support belt is installed between the fixed frame and the upper sealing plate. The utility model can effectively assist mammals to stand stably after surgery by using the cage to restrict the movements of mammals and lift their abdomens, avoid ischemic necrosis of the hind limbs when lying prone, and facilitate inspection and drug administration operations on mammals.

To provide a mammalian epilepsy model.SOLUTION: A mammalian epilepsy model is obtained by a method comprising (i) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into three or more different brain or cranial nerve regions of a mammal; or (ii) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into two or more different brain or cranial nerve regions of a mammal and injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into one or more different brain or cranial nerve regions of a mammal.SELECTED DRAWING: None

The present disclosure is directed to a method and device to determine a value of a blood constituent of a mammal. The device includes a plurality of light emitting diodes, one or more sensors and a processor.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

Accordingly, in its first aspect, the present invention relates to a method for fitting clothing items to the anatomical geometry of animal body parts and comprising the steps of: Positioning mammal in a comfortable, free and unforced position; or in a controlled position that forces the exposure of important anatomical features; or in a sequence of movements enforcing the above position to be adopted in a predictable future moment; or in a position with controlled placement in relation to surroundings objects such as floor, walls; Starting a data collection device equipped with an optical system for collecting optical data in essentially real time and configured to communicate with an operator of the device with an at least graphical user interface; Placement of the data collection device basically perpendicularly to the mammal body part axis and in a distance enabling the collection of the optical data about the whole body part and / or surroundings objects; Collection of the optical data; Automatic or manual determining the type of mammal, part of the body visible to the optical system and determining a set of biometric indicators necessary to determine the anatomical geometry of a certain body part of given animal; Presenting in real time the gathered optical data on the electronic interface and indicating to the operator found biometric indicators.

The use of FcγRIIB as a mammalian mammary IgG transport receptor. By constructing FcγRIIB-knockout mice and FcγRIIB-knockout pigs, it is found that the ratio of serum and milk IgG concentrations of the FcγRIIB-knockout mice is significantly increased, that is, the relative concentration of milk IgG is reduced; and the FcγRIIB-knockout pigs have a significantly increased serum IgG content, but IgG is nearly undetectable in colostrum. Therefore, it has been proved for the first time that FcγRIIB is a receptor that mediates the trans-mammary transport of serum IgG to milk, and answers a long-term unsolved problem in the field of maternal passive immunity research. Furthermore, a new strategy is provided for increasing the IgG content of colostrum, thereby improving the early immunity and survival rate of neonatal domestic animals.

This disclosure generally relates to an optical coherence tomography (OCT) system. This disclosure particularly relates to an OCT system with a multi-pass dispersion compensation cell incorporated into its reference arm. This disclosure further relates to a hand-held compact OCT system suitable for inspection of an ear of a mammal.

The present disclosure provides methods of treating factor X deficiency with fitusiran in a mammal in need thereof.

Pharmaceutical compositions, and methods of production and use for the treatment of neoplastic disease in a mammalian animal. When administered to an animal, the pharmaceutical compositions are useful for the treatment of neoplastic diseases such as various cancers, particularly those affecting mammalian animals such as companion animals.

The present invention relates to dispensing instruments and methods for introducing treatment material and fluid-like material with an embryo into a uterus. More specifically, the present invention relates to apparatuses for delivering a fertilized egg or embryo into a maternal uterine endometrium in humans or any other mammalian species and associated computer programs for controlling said apparatuses.

The invention relates to a zero-glue and zero-starch complementary food composition for animals in a weaning period. The zero-glue and zero-starch complementary food composition comprises animal meat, new-resource food raw materials and compound nutrients. The invention also relates to a preparation method of the complementary food composition, the animal complementary food sausage is very suitable for the weaning period animals, is an easily digestible animal complementary food, can help the weaning period animals gradually adapt to the diet process of transition from liquid breast milk to solid staple food grains, and enables the animals to smoothly pass through the weaning period.